Received May 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
swollen redness and very sore injection site; swollen redness and very sore injection site/ tender; swollen redness and very sore injection site; This spontaneous report was received on behalf of physician and refers to a female patient of unknown age. The patient's medical history, current conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) as default pre-filled syringe formulation (strength, exact dose, anatomical route of administration, frequency, lot # and expiration date were not reported) as prophylaxis. On an unknown date, the patient complained of swollen redness and very sore injection site and "she had a swollen arm, red, tender" and not sure how long it started after vaccination was received (vaccination site pain, vaccination site erythema, vaccination site swelling). At the reporting time, the outcome of the events was not reported. The causal relationship between the event of vaccination site pain, vaccination site erythema, and vaccination site swelling with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not provided. Lot number is being requested and will be submitted if received.